Definitive Healthcare Corp. announced on September 2, 2026, that its Special Committee of the Board of Directors has received a non-binding indication of interest from Advent International, L.P. The proposal seeks to acquire all outstanding shares of the Company’s Class A common stock and all outstanding limited liability company interests of AIDH TopCo, LLC (Definitive OpCo Units), excluding those already held by Advent or Jason Krantz, the Company’s founder and Executive Chairman.
The proposal offers an all-cash purchase price of $1.02 per share of Class A common stock, with an equivalent amount offered for each Definitive OpCo Unit. The Special Committee, comprised entirely of disinterested and independent directors, will review the proposal in consultation with independent legal and financial advisors. Rothschild & Co is serving as the Special Committee’s financial advisor, and Skadden, Arps, Slate, Meagher & Flom LLP is serving as its legal counsel.
Evercore is serving as the Company’s financial advisor, and Hogan Lovells Cadwalader is serving as the Company’s legal counsel. The Special Committee will evaluate the proposal to determine the course of action that best serves the interests of the Company and its stockholders. The Company cautions that no decisions have been made regarding the response to the proposal and that there is no assurance a transaction will be approved or consummated.
